Genmab — Juni 2022
-
Janssen Announces U.S. FDA Breakthrough Therapy Designation Granted for Talquetamab for the Treatment of Relapsed or Refractory Multiple Myeloma https://www.prnewswire.com/news-releases/janssen-announces-us-fda-breakthrough-therapy-designation-granted-for-talquetamab-for-the-treatment-of-relapsed-or-refractory-multiple-myeloma-301577835.html
-
J Curve
-
USA/Åbning: Små fald i nervøst marked
https://www.proinvestor.com/investornyt/844027/usa-abning-sma-fald-i-nervost-marked -
Onsdagens aktier: Bavarian toppede risikonervøst marked
https://www.proinvestor.com/investornyt/844105/onsdagens-aktier-bavarian-toppede-risikonervost-marked -
@Pensionisten. Hold da kæft en mulighed. Det må du ikke fortælle til de andre
-
Der sker mange pudsige ting på børserne ved kvartal- og halvårsafslutning.
-
God morgen.
-
Hansen og Larsen lægger sig i denne uge på hjul af SAS's overlevelsesmuligheder ved strejke, og om det er en mulig investeringscase. De kommer også ind på Lundbecks (for en gangs skyld) gode nyheder og de seneste ugers heftige stigninger fra Bavarain Nordic. Lyt til det hele her. https://www.proinvestor.com/boards/104250
-
Aktier/åbning: Vestas i bunden af rødt C25 - kun Genmab klarer frisag
https://www.proinvestor.com/investornyt/844382/aktier-abning-vestas-i-bunden-af-rodt-c25-kun-genmab-klarer-frisag -
Det daglige tilbagekøb bliver begrænset af den lave handelsvolumen, så det udligner i et vist omfang kurspåvirkningen. Men det er trods alt en pæn portion aktier, der "trækkes ud" af markedet dagligt
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind